| Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer KL Bryant, CA Stalnecker, D Zeitouni, JE Klomp, S Peng, AP Tikunov, ... Nature medicine 25 (4), 628-640, 2019 | 639 | 2019 |
| Long-term ERK inhibition in KRAS-mutant pancreatic cancer is associated with MYC degradation and senescence-like growth suppression TK Hayes, NF Neel, C Hu, P Gautam, M Chenard, B Long, M Aziz, ... Cancer cell 29 (1), 75-89, 2016 | 255 | 2016 |
| Low-dose vertical inhibition of the RAF-MEK-ERK cascade causes apoptotic death of KRAS mutant cancers I Ozkan-Dagliyan, JN Diehl, SD George, A Schaefer, B Papke, ... Cell reports 31 (11), 2020 | 90 | 2020 |
| Rho GTPase transcriptome analysis reveals oncogenic roles for Rho GTPase-activating proteins in basal-like breast cancers CD Lawson, C Fan, N Mitin, NM Baker, SD George, DM Graham, ... Cancer research 76 (13), 3826-3837, 2016 | 80 | 2016 |
| A KRAS GTPase K104Q mutant retains downstream signaling by offsetting defects in regulation G Yin, S Kistler, SD George, N Kuhlmann, L Garvey, M Huynh, RK Bagni, ... Journal of Biological Chemistry 292 (11), 4446-4456, 2017 | 44 | 2017 |
| CIB1 depletion impairs cell survival and tumor growth in triple-negative breast cancer JL Black, JC Harrell, TM Leisner, MJ Fellmeth, SD George, D Reinhold, ... Breast cancer research and treatment 152, 337-346, 2015 | 36 | 2015 |
| Hands-On, Instructor-Light, Checked and Tracked Training of Trainers in Java Fork-Join Abstractions P Dewan, A Worley, S George, F Yanaga, A Wortas, J Juschuk, M Rogers, ... 2022 IEEE 29th International Conference on High Performance Computing, Data …, 2022 | 6 | 2022 |
| Author Correction: Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer KL Bryant, CA Stalnecker, D Zeitouni, JE Klomp, S Peng, AP Tikunov, ... Nature medicine 26 (6), 982-982, 2020 | 6 | 2020 |
| Automating testing of visual observed concurrency P Dewan, A Wortas, Z Liu, S George, B Gu, H Wang 2021 IEEE/ACM Ninth Workshop on Education for High Performance Computing …, 2021 | 5 | 2021 |
| Techniques and tools for visually introducing freshmen to object-based thread abstractions P Dewan, S George, A Wortas, J Do Journal of Parallel and Distributed Computing 157, 179-200, 2021 | 5 | 2021 |
| NotebookGPT–Facilitating and Monitoring Explicit Lightweight Student GPT Help Requests During Programming Exercises SD George, P Dewan Companion Proceedings of the 29th International Conference on Intelligent …, 2024 | 3 | 2024 |
| Broad Awareness of Unseen Work on a Concurrency-Based Assignment P Dewan, S George, B Gu, Z Liu, H Wang, A Wortas 2021 IEEE 28th International Conference on High Performance Computing, Data …, 2021 | 2 | 2021 |
| Abstract SY20-02: Inhibitor combinations targeting KRAS effector signaling in KRAS-mutant pancreatic cancer AD Cox, CM Goodwin, KL Bryant, I Dagliyan, SD George, KE Lucas, ... Cancer Research 78 (13_Supplement), SY20-02-SY20-02, 2018 | 2 | 2018 |
| Ras Proteins SD George, CJ Der Elsevier, 2016 | 1 | 2016 |
| Assistant Dashboard Plus–Enhancing an Existing Instructor Dashboard with Difficulty Detection and GPT-based Code Clustering SD George, T Huang, C Robinson, G Schell, W Shan, Z Zhao, Z Zhou, ... Companion Proceedings of the 29th International Conference on Intelligent …, 2024 | | 2024 |
| Predicting Students’ Cell and Assignment Completion Times in Jupyter H Zhang, P Dewan, S George | | 2021 |
| Abstract B15: CRISPR/Cas9 genetic screen identifies novel therapeutic strategies for treating HRAS mutant HNSCC with farnesyltransferase inhibitors (FTIs) CM Goodwin, KL Bryant, SD George, VV Nguyen, KN Lambert, ... Clinical Cancer Research 26 (12_Supplement_2), B15-B15, 2020 | | 2020 |
| CRISPR/Cas9 genetic screen identifies novel therapeutic strategies for treating HRAS mutant HNSCC with farnesyltransferase inhibitors (FTIs) Sehrish-Javaid, CM Goodwin, KL Bryant, SD George, VV Nguyen, ... CLINICAL CANCER RESEARCH 26 (12), 58-59, 2020 | | 2020 |
| Combination inhibitor strategies targeting KRAS effector signaling in KRAS-mutant pancreatic cancer. I Ozkan-Dagliyan, CM Goodwin, KL Bryant, SD George, K Lucas, ... MOLECULAR CANCER RESEARCH 18 (5), 68-68, 2020 | | 2020 |
| Abstract B31: Combination inhibitor strategies targeting KRAS effector signaling in KRAS-mutant pancreatic cancer I Ozkan-Dagliyan, CM Goodwin, KL Bryant, SD George, K Lucas, ... Molecular Cancer Research 18 (5_Supplement), B31-B31, 2020 | | 2020 |
